On Demand

There are a flurry of policies and changing industry dynamics impacting pricing and commercialization strategy. The Inflation Reduction Act, the AMP cap removal on Medicaid Drugs, and the movement to cash certainly impact pricing and access strategies and tactics, but how exactly?

Join Jeff Baab and Nick Iaconi for key insights on healthcare policy as we move into 2024.

Jeff Baab
VP, Operational Consulting

Nick Iaconi
Senior Manager, Operational Consulting